Literature DB >> 30042412

Questions arising on phlebotomy in polycythemia vera: prophylactic measures to reduce thromboembolic events require patient-focused decisions.

Florian H Heidel1, Haifa-Kathrin Al-Ali2, Carsten Hirt3, Dietrich Kämpfe4, Kathleen Jentsch-Ullrich5, Christian Junghanss6, Ralf Nowak7, Andreas Schwarzer8, Claudia Spohn9, Vladan Vucinic10, Andreas Hochhaus11, Thoralf Lange12.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30042412     DOI： 10.1038/s41375-018-0214-x

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  3 in total

1.  Indications and use of therapeutic phlebotomy in polycythemia vera: which role for erythrocytapheresis?

Authors:  Luciana Teofili; Caterina Giovanna Valentini; Elena Rossi; Valerio De Stefano
Journal:  Leukemia       Date:  2018-12-05       Impact factor: 11.528

Review 2.  Polycythemia vera: historical oversights, diagnostic details, and therapeutic views.

Authors:  Ayalew Tefferi; Alessandro M Vannucchi; Tiziano Barbui
Journal:  Leukemia       Date:  2021-09-03       Impact factor: 11.528

3.  Cytoreductive treatment in real life: a chart review analysis on 1440 patients with polycythemia vera.

Authors:  Carl C Crodel; Kathleen Jentsch-Ullrich; Marcel Reiser; Lutz Jacobasch; Annette Sauer; Hans Tesch; Thomas Ulshöfer; Regine Wunschel; Francesca Palandri; Florian H Heidel
Journal:  J Cancer Res Clin Oncol       Date:  2021-11-22       Impact factor: 4.322
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.